EcoR1 Capital
Venture capital firm · Founded 2013 · San Francisco, CA · San Francisco ↗
EcoR1 Capital is a San Francisco-based, biotech-focused investment fund that builds long-term partnerships with entrepreneurs developing new medicines, investing in compelling biotechnology companies across stages of research and development. The firm describes its approach as holistic evaluation targeted at therapeutics that can improve patient lives.
Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
This profile is unclaimed. Built from public sources. If you're a partner or employee at EcoR1 Capital, you can claim it.
Claim this profileHow claiming worksKey numbers
Assets under management
$3.4B
Latest fund
LAST CHECKED NOV 2026
Funds
LAST CHECKED NOV 2026
Check size
LAST CHECKED NOV 2026
Stages
Seed
Sectors
biotechnologytherapeuticslife sciences
FIGURES ARE AS PUBLISHED IN THE CATALOG RECORD 1 · PER-FIGURE AS-OF DATES ARE NOT YET IN THE CATALOG
Track record
Hits
Track record
Misses
Track record
Partners 7
- Oleg Nodelman
Founder + Portfolio Manager
Board seats
3 on record
- Basheer Zada
Principal
Board seats
2 on record
- Caroline Stout
Partner
Board seats
No public record
Areesha SaifAnalyst
Board seats
No public record
Daniel ChizhikovAnalyst
Board seats
No public record
Nima EmamiAnalyst
Board seats
No public record
Whan LeeSenior Analyst
Board seats
No public record
Reputation 2
No reputation score — basis not established for this firm.
- Nuvation Bio IPO profile (EcoR1 sponsor) - Renaissance Capital
renaissancecapital.com
Contact
Published sources only
Published contact
- Website
- www.ecor1cap.com/
Published sources only
GlassVC lists only contact information the firm or its sources have published. We do not list personal emails, direct lines, or private addresses.
SOURCE: FIRM WEBSITE, AS PUBLISHED 2
What founders say
Founder-submitted · Verified identity and relationship
No founder reviews yet
Be the first founder to share your experience with EcoR1 Capital. Reviews come from founders whose identity and relationship have been verified.
Write the first reviewMethodology
Tier basis — No AUM or fund size is stated anywhere on the firm's own site (fetched 2026-11-17), so no AUM/fund-size tier rule fires. Staged Tier 4 on activity evidence only: operating since 2013 per the founder's profile, with partners holding current board seats at public biotech companies. Captain may override. Tier reflects published scale and track-record signals. It is not a rating of the firm as a partner.
Figures are shown as published; conflicting figures are never averaged. Review dimension scores appear only once three founders have reviewed this firm; profiles below that threshold do not appear in rated lists.
The catalog does not yet carry per-figure citations or as-of dates: every figure on this page traces to the catalog record listed below, and that limit is stated rather than papered over. Corrections with a source: Suggest a correction.
Source record 2
- [1]
DATABASE · GlassVC catalog — Catalog record for EcoR1 Capital — provenance: GlassVC editorial — entered manually
↩ cites: AUM · Check size · Founded · HQ · Stages · Sectors · Reputation
- [2]
FIRM SITE · EcoR1 Capital — Firm website, as published by the firm
PROFILE BUILT FROM PUBLIC SOURCES · 2 CATALOG SOURCES · LAST CHECKED NOV 2026
